Journal of Genetic Medicine : eISSN 2383-8442 / pISSN 1226-1769

Fig. 2.

Download original image
Fig. 2. Changes of biomarkers during one-year eliglustat therapy: serum angiotensin converting enzyme (normal reference: 20-70 U/L) (A), serum total acid phosphatase (normal reference: 0.0-6.4 U/L) (B), and lyso-Gb1 in dried blood spot (normal reference: <10 ng/mL) (C).
Journal of Genetic Medicine 2020;17:62-7 https://doi.org/10.5734/JGM.2020.17.2.62
© 2020 Korean Society of Medical Genetics and Genomics